Mini-invasive surgical instruments in transaortic myectomy for hypertrophic obstructive cardiomyopathy: a single-center experience with 168 cases

Table 3 Incidence of major adverse events per surgeon

Number	^aVolume	^bMajor adverse events (number of patients)	Incidence	p
Surgeon 1	72	CAVB (2), residual MR (1)	4.2%	0.739
Surgeon 2	36	Death (1), CAVB (1), residual obstruction (1)	8.3%
Surgeon 3	23	CAVB (1), residual obstruction (1)	8.7%
Surgeon 4	14	CAVB (1)	7.1%
Surgeon 5	13	Residual MR (1)	7.7%
Surgeon 6	10	Residual obstruction (1)	10.0%

^aVolume, total number of myectomy procedures during the three-year period
^bMajor adverse events, postoperative adverse events including deaths, complete atrioventricular block, residual obstruction, and residual moderate or more mitral regurgitation

ISSN: 1749-8090